SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel ($INTC) is trending following a Q3 earnings beat, with much discussion around revenue growth and AI prospects. Community members are weighing profit-taking strategies against potential upside from new partnerships and government support. Bullish sentiment is fueled by the possibility of Intel regaining market share and the potential for a short squeeze.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending as Q3 sales numbers have been released, showing an overall increase driven by trucks and SUVs. Community members are discussing whether this sales momentum can continue, especially with the EV tax credit expiring and the impact of recent supplier issues. Many are also closely watching for a potential Trump-era tariff relief, which could significantly benefit Ford's bottom line.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

Recursion Pharmaceuticals Inc

RXRX is trending due to community enthusiasm around its AI-driven drug discovery platform, compounded by NVIDIA's investment and a presentation at the GITEX Global conference in Dubai. Talk centers on the potential for a short squeeze given the stock's high short interest. Bullish sentiment is also driven by the company's expansion potential in the Middle East.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers is trending as analysts are updating ratings and price targets, influencing investor sentiment. Community members are actively discussing potential catalysts, tariff impacts, and the strength of the Hoka and UGG brands. The stock's recent volatility and oversold conditions are also fueling discussions around swing trading opportunities and long-term recovery.

Above Food Ingredients, Inc. engages in operating its subsidiaries, Bite Acquisition Corp. (Bite) and Above Food Corp. (Above Food). The Bite is a blank check company that affects a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Above Food is an ingredient company that provides food products and brands. The company was founded by Lionel Kambeitz on April 18, 2023 and is headquartered in Regina, Canada.

Above Food Ingredients Inc.

ABVE is trending due to anticipation surrounding its merger with Palm Global and potential access to significant gold-backed assets, with the community closely watching for news and updates on the deal's progress. Traders are actively discussing potential short squeezes and the impact of upcoming financial audits and partnership announcements. Overall sentiment suggests a mix of excitement and impatience as investors await further catalysts.

$BALLIN is the perfect meme for everyone showing up every single day.  To be BALLIN, you gotta B-All-In.  The meaning to B All In doesn't only apply to the funds you invest.  It's about dedication.   The countless hours of research.   The endless raiding and working for your bags.  Not knowing how to quit while everyone is telling you you're wrong.  It's about believing in something.  Keep $BALLIN

B All In

The crypto, BALLIN, is gaining attention, particularly within the Phantom Wallet community, with many touting its potential for significant gains. Community members emphasize a "winners" and "high roller" culture, promoting it as a lifestyle choice. However, some users are also reporting concerns about potential scams.

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.

Inhibrx Biosciences Inc.

Inhibrx Inc

Inhibrx (INBX) is trending due to positive trial results for their drug Ozekibart in treating chondrosarcoma, a rare bone cancer, leading to significant pre-market gains. The community is discussing the potential for a "PRAX-move," referencing another stock that experienced a substantial surge, while also considering potential cash offerings. Some traders are eyeing high price targets, viewing INBX as a first-mover in a market with currently no approved systemic treatment options for the disease.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Grayscale Bitcoin Mini Trust ETF ($BTC) is trending as Bitcoin flirts with all-time highs, fueling community excitement about potential gains. The ETF's movements are closely tied to Bitcoin's price, with discussions focusing on key support and resistance levels. Some investors are also weighing $BTC against other assets like gold and AI-related stocks.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont Corp ($NEM) is trending as investors react to strong earnings, although some are concerned about production warnings and a potential cash flow dip in the coming quarter. Community discussions revolve around whether the earnings justify the stock's recent drop and speculate on potential market manipulation. Despite the mixed sentiment, some analysts remain bullish, citing the potential for gold to reach new highs and the company's overall financial health.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is trending due to a recently received milestone payment of $30 million related to its ziftomenib AML program, sparking optimism about the drug's potential and the company's financial position. The community is discussing the timing of the PR in relation to competitor SNDX's PDUFA date, speculating on potential FDA receptiveness to menin inhibitors. Some investors believe KURA's pipeline is undervalued, with its valuation not fully reflecting the potential of its drugs and strategic partnerships.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oppenheimer downgrades bank stocks

Investing.com -- Oppenheimer has downgraded several bank stocks, including Cohen&Company, Goldman Sachs, and Jefferies, to Perform in a note Wednesday due to concerns about a delayed or canceled rebound in merger and acquisition (M&A) activity.

Shares of financial services firm Cohen &amp; Company Inc. (COHN) declined over 4% on Monday after the company announced <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/03/10/3039706/0/en/Cohen-Company-Reports-Fourth-Quarter-Full-Year-2024-Financial-Results.html">losses</a> in the fourth quarter compared to a net profit in the year-ago period.Revenue declined 46% year-over-year (YoY) to $18.54 million but came in better than a Wall Street estimate of $9.38 million, according to Stocktwits data. Adjusted losses stood at $1.32 per share compared to a projected loss of $1.90.The company reported a net loss of $1.95 million compared to a net income of $4.55 million in the same quarter a year ago.Net trading revenue rose to $8.9 million during the quarter compared to $7.8 million in the same quarter a year ago, primarily due to higher trading revenue from the mortgage group.Asset management revenue increased to $2.07 million from $1.92 million in the year-ago period, driven by deferred performance fees in one of the company’s European funds.New issue and advisory revenue fell to $10.08 million from $18.72 million in the year-ago quarter.CEO Lester Brafman explained that in 2024, the company’s full-service boutique investment bank, Cohen &amp; Company Capital Markets (CCM), continued to grow market share as an advisor and agent, expanding into underwriting initial public offerings.“While CCM revenue was down compared to the third quarter of 2024, our actions to strengthen the business throughout the year generated full-year CCM revenue of $38.9 million from nearly 50 clients, almost double the full-year 2023 CCM revenue of $21.9 million,” he said.Brafman also highlighted that despite continued elevated mortgage rates and lower mortgage origination levels, the company grew its mortgage business in 2024, ending the year with a gestation repo book of $2.7 billion, up more than 30% from December 2023.Meanwhile, on Stocktwits, retail sentiment continued to trend in the ‘neutral’ territory (50/100) following the earnings announcement.<figure class="image"><img style="aspect-ratio:1854/422;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_03_10_at_10_16_23_AM_c270f14bc5.png" alt="COHN’s Sentiment Meter and Message Volume as of 9:49 a.m. ET on March 10, 2025 | Source: Stocktwits" width="1854" height="422"><figcaption>COHN’s Sentiment Meter and Message Volume as of 9:49 a.m. ET on March 10, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/COHN">COHN shares</a> have declined over 12% year-to-date but are up over 17% in the past year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/redfin-stock-surges-premarket-aftger-rocket-companies-deal/cheUsBtRbbe">Redfin Stock Surges 75% Pre-Market After Rocket Companies Agrees To Acquire Company In $1.75B Deal: Retail Cheers The Deal</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Cohen & Company Stock Falls After Company Registers Losses In Fourth Quarter — Retail’s On The Fence

Revenue declined 46% year-over-year to $18.54 million but came in better than a Wall Street estimate of $9.38 million, according to Stocktwits data. Adjusted losses stood at $1.32 per share compared to a projected loss of $1.90.

Equity

As the broader market grapples with recession fears on Monday, a select group of stocks has managed to capture the attention and optimism of retail investors. Here’s how Stocktwits users feel about them as of 1:00 pm ET.United Homes Group (UHG): Despite nearly 20% decline in its share price on Monday, UHG has garnered immense retail interest, with Stocktwits sentiment currently trending in the ‘extremely bullish’ zone (95/100).<figure class="image"><a href="https://stocktwits.com/symbol/UHG"><img style="aspect-ratio:1302/304;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/UHG_30f8692dc9.png" alt="UHG.png" width="1302" height="304"></a><figcaption>UHG sentiment and message volume score Aug 5.</figcaption></figure>The company, primarily focused on homebuilding in South Carolina, is set to release Q2 earnings on Thursday. While Q1 saw a decline in new home orders and backlogs, the average selling price increased 7% year-over-year to $335,000.Notably, insiders made significant stock purchases in June, signaling confidence in the company's future.Cohen &amp; Company (COHN): The wealth management firm has experienced a surge in retail optimism, with Stocktwits sentiment flipping to ‘extremely bullish’ (94/100) following its Q2 earnings report.<figure class="image"><a href="https://stocktwits.com/symbol/COHN"><img style="aspect-ratio:1304/306;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/COHN_a6c5200f7c.png" alt="COHN.png" width="1304" height="306"></a><figcaption>COHN sentiment and message volume score Aug 5.</figcaption></figure>Despite adjusted loss widening to $1.51 per share from $0.30 in the prior year, the company emphasized its focus on enhancing long-term value and maintaining dividend payments.American Axle &amp; Manufacturing (AXL): The driveline systems maker’s stock has garnered strong retail support despite a 4% decline in share price.While BofA maintains an ‘underperform’ rating, citing macroeconomic challenges, retail investors appear optimistic about the company's ability to navigate industry headwinds.<figure class="image"><a href="https://stocktwits.com/symbol/AXL"><img style="aspect-ratio:1302/308;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/AXL_12008a0261.png" alt="AXL.png" width="1302" height="308"></a><figcaption>AXL sentiment and message volume score Aug 5.</figcaption></figure>The company is due to announce Q2 results on Friday, Aug. 9th, before the market opens, with Wall Street expecting EPS of $0.11. It has beaten EPS estimates in three of the past four quarters.Mesa Laboratories (MLAB): The life sciences company has captured retail attention with ‘extremely bullish’ sentiment on Stocktwits. A strong Q1 earnings report, including a beat on EPS and debt reduction, has fueled investor optimism.<figure class="image"><a href="https://stocktwits.com/symbol/MLAB"><img style="aspect-ratio:1298/300;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/MLAB_71589e870f.png" alt="MLAB.png" width="1298" height="300"></a><figcaption>MLAB sentiment and message volume score Aug 5.</figcaption></figure>However, a recent price target cut by Evercore ISI to $106 from $120 might introduce some caution. The company's ability to maintain its strong financial performance will be essential for sustaining investor confidence.

UHG, COHN, AXL, MLAB: Retail Extremely Bullish On These 4 Stocks Amid Market Rout

A select group of stocks like UHG, COHN, AXL, MLAB has managed to capture the attention and optimism of retail investors. Here’s how Stocktwits users feel about them as of 1:00 pm ET.

UHG, COHN, AXL, and MLAB: Retail Investors Show Bullish Sentiment on These Stocks

With markets caught in a sell-off storm, these stocks have managed to attract significant retail investor attention due to a combination of factors including strong earnings, positive business outlooks, and insider buying activity.

Cohen & Co., Inc. engages in fixed income markets. It operates through the following segments: Capital Markets, Asset Management, and Principal Investing. The Capital Markets segment consists of fixed income sales, trading, matched book repo financing, and new issue placements in corporate and securitized products and advisory services, operating primarily through its subsidiaries. The Asset Management segment manages assets through investment vehicles, such as collateralized debt obligations, managed accounts, and investment funds. The Principal Investing segment includes investments that made for the purpose of earning an investment return. The company was founded in 1999 and is headquartered in Philadelphia, PA.

COHN
Cohen & Company Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest COHN News

COHNCohen & Company Inc